Does RELUGOLIX Cause Coronary arterial stent insertion? 9 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Coronary arterial stent insertion have been filed in association with RELUGOLIX (Orgovyx). This represents 0.0% of all adverse event reports for RELUGOLIX.
9
Reports of Coronary arterial stent insertion with RELUGOLIX
0.0%
of all RELUGOLIX reports
0
Deaths
4
Hospitalizations
How Dangerous Is Coronary arterial stent insertion From RELUGOLIX?
Of the 9 reports, 4 (44.4%) required hospitalization.
Is Coronary arterial stent insertion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RELUGOLIX. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does RELUGOLIX Cause?
Hot flush (6,845)
Fatigue (5,203)
Therapy interrupted (3,251)
Incorrect dose administered (1,917)
Asthenia (1,718)
Arthralgia (1,385)
Diarrhoea (1,383)
Product dose omission issue (1,189)
Dizziness (1,146)
Constipation (902)
What Other Drugs Cause Coronary arterial stent insertion?
ROSIGLITAZONE (1,698)
METFORMIN\ROSIGLITAZONE (245)
ADALIMUMAB (175)
EVOLOCUMAB (109)
RANOLAZINE (95)
RISANKIZUMAB-RZAA (94)
AVANDIA (68)
ETANERCEPT (67)
IBRUTINIB (54)
UPADACITINIB (52)
Which RELUGOLIX Alternatives Have Lower Coronary arterial stent insertion Risk?
RELUGOLIX vs REMDESIVIR
RELUGOLIX vs REMERON
RELUGOLIX vs REMICADE
RELUGOLIX vs REMIFENTANIL
RELUGOLIX vs REMIMAZOLAM